D. Leistner and A. Zeiher, Novel Avenues for Cell Therapy in Acute Myocardial Infarction, Circulation Research, vol.110, issue.2, pp.195-197, 2012.
DOI : 10.1161/CIRCRESAHA.111.260281

S. Janssens, Stem Cells in the Treatment of Heart Disease, Annual Review of Medicine, vol.61, issue.1, pp.287-300, 2010.
DOI : 10.1146/annurev.med.051508.215152

T. Li, M. Kubo, K. Ueda, M. Murakami, A. Mikamo et al., Impaired angiogenic potency of bone marrow cells from patients with advanced age, anemia, and renal failure, The Journal of Thoracic and Cardiovascular Surgery, vol.139, issue.2, pp.459-465, 2010.
DOI : 10.1016/j.jtcvs.2009.07.053

C. Kissel, R. Lehmann, B. Assmus, A. Aicher, J. Honold et al., Selective Functional Exhaustion of Hematopoietic Progenitor Cells in the Bone Marrow of Patients With Postinfarction Heart Failure, Journal of the American College of Cardiology, vol.49, issue.24, pp.2341-2349, 2007.
DOI : 10.1016/j.jacc.2007.01.095

S. Dimmeler and A. Leri, Aging and Disease as Modifiers of Efficacy of Cell Therapy, Circulation Research, vol.102, issue.11, pp.1319-1330, 2008.
DOI : 10.1161/CIRCRESAHA.108.175943

D. Stefano, R. Barsotti, M. , F. F. Magera, A. Lekakis et al., Smoking and Endothelial Progenitor Cells: A Revision of Literature, Current Pharmaceutical Design, vol.16, issue.23, pp.2559-2566, 2010.
DOI : 10.2174/138161210792062939

B. Assmus, U. Fischer-rasokat, J. Honold, F. Seeger, S. Fichtlscherer et al., Transcoronary Transplantation of Functionally Competent BMCs Is Associated With a Decrease in Natriuretic Peptide Serum Levels and Improved Survival of Patients With Chronic Postinfarction Heart Failure: Results of the TOPCARE-CHD Registry, Circulation Research, vol.100, issue.8, pp.1234-1241, 2007.
DOI : 10.1161/01.RES.0000264508.47717.6b

X. Wang, J. Takagawa, V. Lam, D. Haddad, D. Tobler et al., Donor Myocardial Infarction Impairs the Therapeutic Potential of Bone Marrow Cells by an Interleukin-1-Mediated Inflammatory Response, Science Translational Medicine, vol.3, issue.100, pp.100-190, 2011.
DOI : 10.1126/scitranslmed.3002814

J. Roncalli, F. Mouquet, C. Piot, J. Trochu, L. Corvoisier et al., Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial, European Heart Journal, vol.32, issue.14, pp.1748-1757, 2011.
DOI : 10.1093/eurheartj/ehq455
URL : https://hal.archives-ouvertes.fr/inserm-00543644

D. Sutherland, L. Anderson, M. Keeney, and R. Nayar, The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry, Journal of Hematotherapy, vol.5, issue.3, pp.213-226, 1996.
DOI : 10.1089/scd.1.1996.5.213

C. Schmidt-lucke, S. Fichtlscherer, A. Aicher, C. Tschope, H. Schultheiss et al., Quantification of Circulating Endothelial Progenitor Cells Using the Modified ISHAGE Protocol, PLoS ONE, vol.103, issue.24, p.13790, 2010.
DOI : 10.1371/journal.pone.0013790.t001

C. Schmidt-lucke, L. Rossig, S. Fichtlscherer, M. Vasa, M. Britten et al., Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair, Circulation, vol.111, issue.22, pp.2981-2987, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.504340

S. Mollema, V. Delgado, M. Bertini, M. Antoni, E. Boersma et al., Viability Assessment With Global Left Ventricular Longitudinal Strain Predicts Recovery of Left Ventricular Function After Acute Myocardial Infarction, Circulation: Cardiovascular Imaging, vol.3, issue.1, pp.15-23, 2010.
DOI : 10.1161/CIRCIMAGING.108.802785

T. Umemura and Y. Higashi, Endothelial Progenitor Cells: Therapeutic Target for Cardiovascular Diseases, Journal of Pharmacological Sciences, vol.108, issue.1, pp.1-6, 2008.
DOI : 10.1254/jphs.08R01CP

M. Vasa, S. Fichtlscherer, A. Aicher, K. Adler, C. Urbich et al., Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease, Circulation Research, vol.89, issue.1, pp.1-7, 2001.
DOI : 10.1161/hh1301.093953

F. Seeger, T. Rasper, M. Koyanagi, H. Fox, A. Zeiher et al., CXCR4 Expression Determines Functional Activity of Bone Marrow-Derived Mononuclear Cells for Therapeutic Neovascularization in Acute Ischemia, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, issue.11, pp.1802-1809, 2009.
DOI : 10.1161/ATVBAHA.109.194688

L. Zornoff, B. Matsubara, L. Matsubara, M. Minicucci, P. Azevedo et al., Paiva SA: [Cigarette smoke exposure intensifies ventricular remodeling process following myocardial infarction], Arq Bras Cardiol, vol.86, pp.276-282, 2006.

F. Villarreal, D. Hong, and J. Omens, Nicotine-modified postinfarction left ventricular remodeling, Am J Physiol, vol.276, pp.1103-1106, 1999.

H. Johnson, L. Gossett, M. Piper, S. Aeschlimann, C. Korcarz et al., Effects of Smoking and Smoking Cessation on Endothelial Function, Journal of the American College of Cardiology, vol.55, issue.18, pp.1988-1995, 2010.
DOI : 10.1016/j.jacc.2010.03.002

M. Yoder, Is Endothelium the Origin of Endothelial Progenitor Cells?, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.30, issue.6, pp.1094-1103, 2010.
DOI : 10.1161/ATVBAHA.109.191635

T. Kondo, M. Hayashi, K. Takeshita, Y. Numaguchi, K. Kobayashi et al., Smoking Cessation Rapidly Increases Circulating Progenitor Cells in Peripheral Blood in Chronic Smokers, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.8, pp.1442-1447, 2004.
DOI : 10.1161/01.ATV.0000135655.52088.c5

A. Leone, M. Valgimigli, M. Giannico, V. Zaccone, M. Perfetti et al., From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells, European Heart Journal, vol.30, issue.8, pp.890-899, 2009.
DOI : 10.1093/eurheartj/ehp078

G. Fadini, D. Losordo, and S. Dimmeler, Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use, Circulation Research, vol.110, issue.4, pp.624-637, 2012.
DOI : 10.1161/CIRCRESAHA.111.243386

N. Werner, S. Kosiol, T. Schiegl, P. Ahlers, K. Walenta et al., Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes, New England Journal of Medicine, vol.353, issue.10, pp.999-1007, 2005.
DOI : 10.1056/NEJMoa043814

G. Fadini, S. Maruyama, T. Ozaki, A. Taguchi, J. Meigs et al., Circulating Progenitor Cell Count for Cardiovascular Risk Stratification: A Pooled Analysis, PLoS ONE, vol.24, issue.7, p.11488, 2010.
DOI : 10.1371/journal.pone.0011488.t004

F. Grundmann, C. Scheid, D. Braun, C. Zobel, H. Reuter et al., Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction, Clinical Research in Cardiology, vol.285, issue.9, pp.621-627, 2007.
DOI : 10.1007/s00392-007-0543-7

B. Assmus, T. Tonn, F. Seeger, C. Yoon, D. Leistner et al., Red Blood Cell Contamination of the Final Cell Product Impairs the Efficacy of Autologous Bone Marrow Mononuclear Cell Therapy, Journal of the American College of Cardiology, vol.55, issue.13, pp.1385-1394, 2010.
DOI : 10.1016/j.jacc.2009.10.059

E. Martin-rendon, S. Brunskill, C. Hyde, S. Stanworth, A. Mathur et al., Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review, European Heart Journal, vol.29, issue.15, pp.1807-1818, 2008.
DOI : 10.1093/eurheartj/ehn220

A. Williams and J. Hare, Mesenchymal Stem Cells: Biology, Pathophysiology, Translational Findings, and Therapeutic Implications for Cardiac Disease, Circulation Research, vol.109, issue.8, pp.923-940, 2011.
DOI : 10.1161/CIRCRESAHA.111.243147

F. Loffredo, M. Steinhauser, J. Gannon, and R. Lee, Bone Marrow-Derived Cell Therapy Stimulates Endogenous Cardiomyocyte Progenitors and Promotes Cardiac Repair, Cell Stem Cell, vol.8, issue.4, pp.389-398, 2011.
DOI : 10.1016/j.stem.2011.02.002

S. Fazel, M. Cimini, L. Chen, S. Li, D. Angoulvant et al., Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines, Journal of Clinical Investigation, vol.116, issue.7, pp.1865-1877, 2006.
DOI : 10.1172/JCI27019DS1

S. Janssens, Cardiac bone marrow cell therapy: the proof of the pudding remains in the eating, European Heart Journal, vol.32, issue.14, pp.1697-1700, 2011.
DOI : 10.1093/eurheartj/ehq513

R. Sargent, R. Shepard, and S. Glantz, Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study, BMJ, vol.328, issue.7446, pp.977-980, 2004.
DOI : 10.1136/bmj.38055.715683.55

J. Pell, S. Haw, S. Cobbe, D. Newby, A. Pell et al., Smoke-free Legislation and Hospitalizations for Acute Coronary Syndrome, New England Journal of Medicine, vol.359, issue.5, pp.482-491, 2008.
DOI : 10.1056/NEJMsa0706740

J. Sargent, E. Demidenko, D. Malenka, Z. Li, H. Gohlke et al., Smoking restrictions and hospitalization for acute coronary events in Germany, Clinical Research in Cardiology, vol.100, issue.3, pp.227-235, 2012.
DOI : 10.1007/s00392-011-0385-1

F. Mouquet, G. Lemesle, C. Delhaye, C. Charbonnel, A. Ung et al., The Presence of Apoptotic Bone Marrow Cells Impairs the Efficacy of Cardiac Cell Therapy, Cell Transplantation, vol.20, issue.7, pp.1087-1097, 2011.
DOI : 10.3727/096368910X544924

D. Smadja, J. Duong-van-huyen, L. Cortivo, A. Blanchard, P. Bruneval et al., Early endothelial progenitor cells in bone marrow are a biomarker of cell therapy success in patients with critical limb ischemia, Cytotherapy, vol.14, issue.2, pp.232-239, 2012.
DOI : 10.3109/14653249.2011.627917

D. Walter, H. Krankenberg, J. Balzer, . Kalkac, . Baumgartneri et al., PROVASA Investigators: Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA) Circ Cardiovasc Interv, pp.26-37, 2011.